Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0029713 (
immaturity
)
4,335
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Mitogen-stimulated spleen cells from newborn mice do not synthesize mRNA for the 55-kDa
interleukin-2 receptor
(IL-2R). The kinetic of development after birth of ability to synthesize IL-2R correlated well with the functional
immaturity
of T cells, as was tested by responsiveness to T-cell mitogen concanavalin A (Con A). This functional
immaturity
of T cells was not due to the activity of neonatal suppressor cells (NSC) which inhibited immune responses induced by mitogens or antigens. The suppressor cells did not inhibit proliferation of spleen cells stimulated with IL-1 or IL-2, nor did they inhibited expression of genes for tumor necrosis factor (TNF)-beta, TNF-alpha, and IL-2R in stimulated cells from adult mice. The results thus show functional
immaturity
of T cells in newborn mice and selectivity of the immunosuppressive action of NSC, which allow for production and for functional activity of cytokines at a time when the specific immune system is not functional because of both
immaturity
and a selective activity of inhibitory cells.
...
PMID:Immunological nonreactivity of newborn mice: immaturity of T cells and selective action of neonatal suppressor cells. 183 88
Surface phenotype of peripheral blood lymphocytes (PBL) from preterm infants was evaluated using monoclonal antibodies which define T cell membrane antigens associated with processes of maturation and activation of these cells. In the majority of preterm infants born during the 25th and 26th week of gestation, PBL included higher percentages of cells bearing an immature/activated surface phenotype characterized by the presence of CD1, CD38, and CD71 surface antigens than in term newborns. In these gestational age groups, PBL included, in particular, very high percentages of lymphocytes (range: 22-60) expressing the p55 chain of
interleukin-2 receptor
(IL-2R). After the 26th week of gestation, PBL of some preterm neonates included, as well, high percentages of lymphocytes bearing immature/activated phenotype; their median values, however, were not significantly different from those observed in term newborns. Our data suggest that the presence of the p55 chain of IL-2R on the surface of neonatal lymphocytes could be correlated with the
immaturity
of these cells.
...
PMID:Lymphocyte subpopulations in preterm infants: high percentage of cells expressing P55 chain of interleukin-2 receptor. 207 24
The morphology of cortical neurons grafted into (or near) the rat striatum was studied by means of intracellular Lucifer yellow injections in fixed slices. Rat donor syngeneic cortical tissue (from postnatal day 1 old rats; AO strain) as well as mouse donor xenogeneic cortical tissue (prenatal day 19; C3H/HE strain) were grafted as solid pieces into 8-12 week-old rats (AO strain). Recipients of mouse xenografts were immunosuppressed with a monoclonal antibody against the
interleukin-2 receptor
. After perfusion and sectioning of the graft-containing areas, individual slices were incubated in the DNA stain 4.6-diamidino-2-phenylindole (DAPI) to visualize the cell nuclei. Grafts could be easily identified by a surrounding rim of astrocytes which outline the border between grafted and host tissue. Grafted cortical neurons were intracellularly filled with Lucifer yellow, DAB-photoconverted, and further processed for light and electron microscopy. In general, no cortical lamination could be observed in the grafted rat and mouse cortical tissue, but neurons were loosely packed throughout the graft. Two major cell types could be identified in all grafts investigated so far. The majority resembled those described as spiny neurons (85%), which could be further classified into pyramid-like, spiny stellate-like or fusiform spiny neurons, with somata ranging between 15 and 25 microns in diameter. The remaining 15% resembled non-spiny neurons with either a multipolar basket-like or fusiform morphology. Dendrites of spiny and non-spiny neurons, which could extend to distances up to 400 microns, were never seen to cross the astrocytic border, but some main axon and axonal collaterals of spiny neurons were found to leave the graft. On the basis of light microscopic observations no difference was found between mouse and rat grafted cortical neurons. The results of this study show that grafted cortical neurons retain some of the characteristic features of neurons in the intact adult cerebral cortex, although there appears to be a greater preponderance of spiny neurons in grafted tissue. This may reflect an
immaturity
of the grafted tissue or a response to the striatal environment.
...
PMID:Morphological assessment of grafted rat and mouse cortical neurons: a light and electron microscopic study. 800 25
While assessing the prognostic implications of immunophenotyping in 382 patients enrolled in treatment protocols of the Eastern Cooperative Oncology Group (ECOG) for de novo adult acute myeloid leukaemia, we identified 95 patients with a unique antigen profile characterized by high expression of the leucocyte integrin CD11b (CD11b+ AML). High expression of CD11b was defined as > or = 32% positive blasts based on the retrospectively established prognostic cut-off point for this antigen. Although CD11b is normally expressed by mature monocytes, natural killer cells and granulocytes, leukaemic blasts in CD11b+ AML lacked other immunologic monocytic features (e.g. CD14 and CD122, the
interleukin-2 receptor
beta chain) and demonstrated a high degree of
immaturity
, as reflected by a high incidence of blasts expressing the stem cell factor receptor, CD117, and few blasts positive for the myeloid differentiation antigen CD15. Furthermore, by FAB criteria, only 41% of CD11b+ AML cases were classified as M4/M5. Patients with CD11b+ AML had a low response rate (54%) when compared with acute monocytic leukaemia (AMOL; 82%, P = 0.006) or AML overall (68%, P = 0.031), independent of age, cytogenetic abnormalities and P-glycoprotein expression. Because of its poor prognosis, recognition of CD11b+ AML is clinically warranted and, given its morphologic and cytogenetic ambiguity, must be based on the unique antigen profile.
...
PMID:Acute myeloid leukaemia expressing the leucocyte integrin CD11b-a new leukaemic syndrome with poor prognosis: result of an ECOG database analysis. Eastern Cooperative Oncology Group. 948 12